Open access
Jul 2026
Dihydromyricetin attenuates cholestatic liver injury by suppressing JAK2/STAT3-associated NF-κB inflammatory and apoptotic signaling.
Dihydromyricetin alleviates CLI by suppressing inflammation, oxidative stress, and hepatocyte apoptosis, at least partly through inhibition of the JAK2/STAT3-NF-κB signaling axis.
Yongkang Cheng, Sansan Feng, Ya-Hui Feng et al.
· International Immunopharmaco... · 0 citations